Trial Profile
DASATINIB compassionate use.
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 07 Jul 2011
Price :
$35
*
At a glance
- Drugs Dasatinib (Primary)
- Indications Chronic myeloid leukaemia; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 07 Jul 2011 New trial record